ConductScience.org, home

Paper15091043

Does anticholinergic medication have a role for men with lower urinary tract symptoms/benign prostatic hyperplasia either alone or in combination with other agents?

Reynard JM. Curr Opin Urol, 2004. Cited by 29 papers, by iCite.

Cite this record

ConductScience Library. Does anticholinergic medication have a role for men with lower urinary tract symptoms/benign prostatic hyperplasia either alone or in combination with other agents? Papers, record 15091043. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/15091043

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Does anticholinergic medication have a role for men with lower urinary tract symptoms/benign prostatic hyperplasia either alone or in combination with other agents?
PubMed
Journal
Curr Opin Urol
PubMed
Year
2004
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
29
iCite
Relative citation ratio, by iCite
1.12
iCite
Revised in PubMed
2019-11-08
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Reynard JMJohn M

Source PubMed

Download CSV of authors

Topics16

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Cholinergic AntagonistsMajor topic
Prostatic HyperplasiaMajor topic
Urination DisordersMajor topic
Aged
Aged, 80 and over
Drug Therapy, Combination
Follow-Up Studies
Humans
Male
Middle Aged
Randomized Controlled Trials as Topic
Risk Assessment
Severity of Illness Index
Treatment Outcome
Urinary Bladder Neck Obstruction
Urodynamics

Source PubMed

Download CSV of topics

Cited by12

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 29 citations.

PMIDTitleJournalYearIn PapersSource
40225436Comparison of Intraoperative Blood Loss in Monopolar Transurethral Resection of the Prostate With and Without Two Weeks of Preoperative Dutasteride.Cureus2025https://conductscience.org/library/papers/40225436PubMed
34616555Efficacy of 0.4 mg tamsulosin monotherapy in patients with moderate-to-severe lower urinary tract symptoms.SAGE Open Med2021https://conductscience.org/library/papers/34616555PubMed
34357409[Benign prostatic obstruction-associated symptoms of the lower urinary tract : Treatment with anticholinergics in combination with alpha-blockers].Urologe A2021https://conductscience.org/library/papers/34357409PubMed
33567116Anticholinergics combined with alpha-blockers for treating lower urinary tract symptoms related to benign prostatic obstruction.Cochrane Database Syst Rev2021https://conductscience.org/library/papers/33567116PubMed
32362986Evaluation and Management of Lower Urinary Tract Symptoms After Outlet Surgery for Benign Prostatic Hyperplasia.Curr Bladder Dysfunct Rep2016https://conductscience.org/library/papers/32362986PubMed
28878453Pulsed electromagnetic field with or without exercise therapy in the treatment of benign prostatic hyperplasia.J Phys Ther Sci2017https://conductscience.org/library/papers/28878453PubMed
27582609Medical and Surgical Treatment Modalities for Lower Urinary Tract Symptoms in the Male Patient Secondary to Benign Prostatic Hyperplasia: A Review.Semin Intervent Radiol2016https://conductscience.org/library/papers/27582609PubMed
25032191Current role of treatment in men with lower urinary tract symptoms combined with overactive bladder.Prostate Int2014https://conductscience.org/library/papers/25032191PubMed
24459652Urinary Tract Symptoms (LUTS) Secondary to Benign Prostatic Hyperplasia (BPH) and LUTS/BPH with Erectile Dysfunction in Asian Men: A Systematic Review Focusing on Tadalafil.World J Mens Health2013https://conductscience.org/library/papers/24459652PubMed
19718286Acute urinary retention in benign prostatic hyperplasia: Risk factors and current management.Indian J Urol2007https://conductscience.org/library/papers/19718286PubMed
19705127Place of overactive bladder in male lower urinary tract symptoms.World J Urol2009https://conductscience.org/library/papers/19705127PubMed
16738854Spontaneous versus precipitated AUR: the same?World J Urol2006https://conductscience.org/library/papers/16738854PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/15091043

GET https://conductscience.org/api/papers/v1/15091043/authors